About: Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. It develops Lanifibranor, a novel peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. The company also develops TGF-ß, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. Inventiva S.A. was incorporated in 2011 and is headquartered in Daix, France.
Sector: Healthcare
Industry: Biotechnology
Latest price: $3.88 (-3.24%)
IVA NASDAQ Inventiva Sa
Inventiva Sa share price
IVA price activity
Last Price
$3.880
Change (24hr)
-0.13 USD (3.24%)
Volume
2.50M
Volume (4w avg)
-
Open
$3.98
Day Range
$3.88 - $4.11
Previous Close
$4.01
Last Trade
12 Nov, 9:00 pm GMT+0
Delayed
12 Nov, 9:00 pm GMT+0
IVA price performance
Delayed
12 Nov, 9:00 pm GMT+0
IVA details
IVA Market Signals